Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPACA
2024-514850-59-00Phase 3Authorised
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2025
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of gentamicin and clindamycin in appendicitis (2 arms), sponsored by Amsterdam University Medical Center. Planned start Jan 2025; status: authorised.
02
Drugs
gentamicinclindamycin
03
Conditions
appendicitis
Beyond the preview
Go deeper on 2024-514850-59-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514850-59-00.